Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol.
B S Alexander, M D Wood
Index: J. Pharm. Pharmacol. 39 , 664-666, (1987)
Full Text: HTML
Abstract
The interaction of the enantiomers of mianserin and propranolol with the binding of [3H]5-hydroxytryptamine ([3H]5-HT) to the 5-HT1A, 5-HT1B and 5-HT1C sites, and with the binding of [3H]ketanserin to the 5-HT2 site, has been evaluated in rat brain membranes. A stereoselective interaction at the 5-HT1A, 5-HT1B and 5-HT1C sites was demonstrated for both compounds, with (+)-mianserin being a more potent displacer than (-)-mianserin and (-)-propranolol being more potent than (+)-propranolol. Only mianserin interacted in a stereoselective manner with the 5-HT2 site, (+)-mianserin being the more potent isomer. The stereoselective association of mianserin and propranolol with the 5-HT1A, 5-HT1B and 5-HT1C sites may prove useful in the characterization of these sites.
Related Compounds
Related Articles:
2007-05-01
[Nat. Chem. Biol. 3(5) , 268-273, (2007)]
2009-10-01
[Nat. Chem. Biol. 5 , 765-71, (2009)]
2009-01-01
[J. Am. Coll. Cardiol. 54 , 1137-45, (2009)]
1985-03-01
[Br. J. Pharmacol. 84 , 743-753, (1985)]
1995-02-01
[J. Cardiovasc. Pharmacol. 25 , 268-272, (1995)]